Modern medicine is facing a growing problem of antibiotic resistance, which necessitates the development and implementation of new antibacterial drugs. This paper examines new-generation antibiotics, their mechanisms of action, spectrum of activity, and clinical effectiveness. Special attention is given to innovative approaches, including combination drugs, β-lactamase inhibitors, and promising novel molecules. It is shown that new antibiotics are capable of overcoming microbial resistance and expanding the possibilities for the treatment of severe infections.
Bo'riyev et al. (Fri,) studied this question.